Form 3 RB GLOBAL INC. For: Oct 07 Filed by: Wyant Samuel William
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||||||
1. Name and Address of Reporting Person
*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 10/07/2026 |
3. Issuer Name
and
Ticker or Trading Symbol
RB GLOBAL INC. [ RBA ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check
Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Shares | 1,287 | Employee Stock Purchase Plan | |
| Common Shares | 43,225 | ||
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Restricted Share Unit (2024 RSUs) | (1) | (1) | Common Shares | 1,128 | (2) | D | |
| Restricted Share Unit (2025 RSUs) | (3) | (3) | Common Shares | 7,685 | (2) | D | |
| Restricted Share Unit (2026 RSUs) | (4) | (4) | Common Shares | 1,928 | (2) | D | |
| Employee Stock Option (Right to Buy) | 03/05/2020 (5) | 03/05/2030 | Common Shares | 14,537 | 40.64 | D | |
| Employee Stock Option (Right to Buy) | 02/25/2021 (5) | 02/25/2031 | Common Shares | 9,676 | 54.83 | D | |
| Employee Stock Option (Right to Buy) | 11/10/2021 (5) | 11/10/2031 | Common Shares | 7,375 | 80 | D | |
| Employee Stock Option (Right to Buy) | 11/10/2021 (5) | 11/10/2031 | Common Shares | 7,222 | 90 | D | |
| Employee Stock Option (Right to Buy) | 11/10/2021 (5) | 11/10/2031 | Common Shares | 9,637 | 100 | D | |
| Employee Stock Option (Right to Buy) | 03/15/2022 (5) | 03/15/2032 | Common Shares | 15,725 | 57.7 | D | |
| /s/ Maria Teresa Punsalan, attorney-in-fact for Samuel William Wyant | 10/19/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ritchie Bros. Brings More Ways to Buy and Sell to rbauction.com
- Small Cell Lung Cancer Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and Route of Administration Trends | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca
- Hidradenitis Suppurativa Market Set for Robust Expansion at a rapid CAGR Through 2036: Key Drivers, Trends, and Leading Players | AbbVie, Novartis, UCB Biopharma, Eli Lilly, Institut Pasteur, UCB Bio
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share